CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Actinide›
Library
Actinide

Actinide

Actinide builds U.S. electromagnetic isotope separators and demonstrated research-scale HALEU enrichment.

Operating headquarters
Dallas, TX, US🇺🇸
Founded
2025
Loading
Overview
Analysis
Compare
Employees
News
Library

Actinide - Library

Official pages and third-party coverage in one index.

actinideinc.com·9 items across 3 mapped pages · Crawled Oct 2, 2026·

Topics

Publication type

Content origin
Row density

Official pages and third-party coverage in one index

Press

2 pages
  1. Actinide becomes first startup to ever enrich uranium, producing HALEU/press/actinide-becomes-first-startup-to-ever-enrich-natural-uranium-to-produce-haleu

    Actinide becomes the first startup to enrich natural uranium into HALEU, advancing a secure, scalable fuel supply for next-generation nuclear reactors.

  2. Press/press

    News and press releases from Actinide, the Dallas isotope enrichment company behind Endurance and Fortitude. Media enquiries: [email protected].

Homepage

1 page
  1. Homepage/

    Actinide is building a scalable, U.S.-owned isotope separation platform for medicine, energy, defense, and advanced materials.

Not yet classified

1 page
  1. actinideinc.com/

    Actinide is building a scalable, U.S.-owned isotope separation platform for medicine, energy, defense, and advanced materials.

Coverage

5 items
  1. The Future Is Waiting for the Right Atomsthetechpencil.com/article/actinide-isotope-separation-yb-176-haleu

    Actinide’s Endurance separator produces ytterbium-176 for medicine and research-scale HALEU. Its Fortitude system tests whether configurable isotope manufacturing can scale.

    Sep 2026 · The Tech PencilNews article

  2. Weekly Dose of Optimism #208 — Actinide Becomes First Startup to Enrich Uranium to HALEUnotboring.co/p/weekly-dose-of-optimism-208

    Actinide becomes the first startup to enrich uranium to HALEU using its electromagnetic isotope separator. The achievement expands domestic isotope production capacity.

    Aug 2026 · Not BoringNews article

  3. Securing the Nuclear Supply Chain: How a Texas Startup is Revolutionizing America's Nuclear Futurelindelltv.com/securing-the-nuclear-supply-chain-how-a-texas-startup-is-revolutionizing-americas-nuclear-future/

    Actinide is the first startup to enrich natural uranium into the HALEU range using a modernized calutron built in Texas.

    Aug 2026 · LindellTVNews article

  4. Plano company makes breakthrough on cancer treatment materialyahoo.com/news/science/articles/plano-company-makes-breakthrough-cancer-225051954.html

    Plano-based Actinide Inc. produces Ytterbium-176 for cancer drugs. The company also demonstrated HALEU production with its Endurance particle accelerator.

    Aug 2026 · Yahoo NewsNews article